Nektar Therapeutics | NKTR - Equity Capital And Reserves


Nektar Therapeutics reported $89.83M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Agios Pharmaceuticals USD 1.11B 84M Mar/2026
ALKERMES USD 1.75B 67.76M Mar/2026
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Amgen USD 9.19B 532M Mar/2026
Baxter International USD 6.04B 86M Mar/2026
BioCryst Pharmaceuticals USD -119.15M 268.74M Dec/2025
Biogen USD 18.65B 394.9M Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Cara Therapeutics USD 27.87M 5.06M Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Dr.Reddys Laboratories INR 375.76B 13.67B Dec/2025
Eisai JPY 889.64B 35.21B Dec/2025
Eli Lilly USD 31.2B 4.66B Mar/2026
Esperion Therapeutics USD -301.96M 149.4M Dec/2025
Exelixis USD 2.16B 619K Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
Grifols EUR 6.21B 133.12M Dec/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
Incyte USD 5.62B 455.37M Mar/2026
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
Ironwood Pharmaceuticals USD -264.16M 44M Sep/2025
Karyopharm Therapeutics USD -292.93M 23.67M Dec/2025
MacroGenics USD 55.59M 11.41M Dec/2025
Merck USD 45.88B 6.73B Mar/2026
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Neurocrine Biosciences USD 3.41B 154.3M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Sarepta Therapeutics USD 1.14B 179.5M Dec/2025
Takeda JPY 7.64T 513.39B Dec/2025
Teva Pharmaceutical Industries USD 8.23B 314M Mar/2026
Xencor USD 635.59M 10.27M Dec/2025